These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10663358)

  • 1. Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.
    Holzherr ML; Retallack RW; Gutteridge DH; Price RI; Faulkner DL; Wilson SG; Will RK; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Kent GN; Bhagat CI; Dhaliwal SS; Jamrozik K
    Osteoporos Int; 2000; 11(1):43-51. PubMed ID: 10663358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
    Gutteridge DH; Holzherr ML; Retallack RW; Price RI; Will RK; Dhaliwal SS; Faulkner DL; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Drury PJ; Tran L; Bhagat CI; Kent GN; Jamrozik K
    Calcif Tissue Int; 2003 Jul; 73(1):33-43. PubMed ID: 14506952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
    Tilyard MW; Spears GF; Thomson J; Dovey S
    N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
    Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
    Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
    Need AG; Morris HA; Horowitz M; Nordin BE
    Calcif Tissue Int; 1997 Jul; 61(1):6-9. PubMed ID: 9192503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women.
    Need AG; Kemp A; Giles N; Morris HA; Horowitz M; Nordin BE
    Osteoporos Int; 2002 Jan; 13(1):83-8. PubMed ID: 11883410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
    Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
    Trémollieres FA; Pouilles JM; Ribot C
    Osteoporos Int; 2001; 12(5):385-90. PubMed ID: 11444087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vitamin D in the pathogenesis and treatment of osteoporosis.
    Gallagher JC
    J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovariectomized murine model of postmenopausal calcium malabsorption.
    Kalu DN; Chen C
    J Bone Miner Res; 1999 Apr; 14(4):593-601. PubMed ID: 10234581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F; Nieves J; Shen V; Lindsay R
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.